Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Cancer Hormone Therapy Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Tamoxifen 1.4.3 Aromatase Inhibitors 1.4.4 Antiandrogens 1.4.5 Androgen Synthesis Inhibitors 1.4.6 Other 1.5 Market by Application 1.5.1 Global Cancer Hormone Therapy Drugs Market Share by Application: 2020 VS 2026 1.5.2 Breast Cancer 1.5.3 Prostate Cancer 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Cancer Hormone Therapy Drugs Market Perspective (2015-2026) 2.2 Cancer Hormone Therapy Drugs Growth Trends by Regions 2.2.1 Cancer Hormone Therapy Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Cancer Hormone Therapy Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Cancer Hormone Therapy Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Cancer Hormone Therapy Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Cancer Hormone Therapy Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Cancer Hormone Therapy Drugs Players by Market Size 3.1.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue (2015-2020) 3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Cancer Hormone Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Cancer Hormone Therapy Drugs Market Concentration Ratio 3.2.1 Global Cancer Hormone Therapy Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Cancer Hormone Therapy Drugs Revenue in 2019 3.3 Cancer Hormone Therapy Drugs Key Players Head office and Area Served 3.4 Key Players Cancer Hormone Therapy Drugs Product Solution and Service 3.5 Date of Enter into Cancer Hormone Therapy Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Type (2015-2020) 4.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2021-2026) 5 Cancer Hormone Therapy Drugs Breakdown Data by Application (2015-2026) 5.1 Global Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) 5.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Cancer Hormone Therapy Drugs Market Size (2015-2020) 6.2 Cancer Hormone Therapy Drugs Key Players in North America (2019-2020) 6.3 North America Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) 6.4 North America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Cancer Hormone Therapy Drugs Market Size (2015-2020) 7.2 Cancer Hormone Therapy Drugs Key Players in Europe (2019-2020) 7.3 Europe Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) 7.4 Europe Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) 8 China 8.1 China Cancer Hormone Therapy Drugs Market Size (2015-2020) 8.2 Cancer Hormone Therapy Drugs Key Players in China (2019-2020) 8.3 China Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) 8.4 China Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Cancer Hormone Therapy Drugs Market Size (2015-2020) 9.2 Cancer Hormone Therapy Drugs Key Players in Japan (2019-2020) 9.3 Japan Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) 9.4 Japan Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Cancer Hormone Therapy Drugs Market Size (2015-2020) 10.2 Cancer Hormone Therapy Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) 11 India 11.1 India Cancer Hormone Therapy Drugs Market Size (2015-2020) 11.2 Cancer Hormone Therapy Drugs Key Players in India (2019-2020) 11.3 India Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) 11.4 India Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Cancer Hormone Therapy Drugs Market Size (2015-2020) 12.2 Cancer Hormone Therapy Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) 12.4 Central & South America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Roche 13.1.1 Roche Company Details 13.1.2 Roche Business Overview and Its Total Revenue 13.1.3 Roche Cancer Hormone Therapy Drugs Introduction 13.1.4 Roche Revenue in Cancer Hormone Therapy Drugs Business (2015-2020)) 13.1.5 Roche Recent Development 13.2 Amgen 13.2.1 Amgen Company Details 13.2.2 Amgen Business Overview and Its Total Revenue 13.2.3 Amgen Cancer Hormone Therapy Drugs Introduction 13.2.4 Amgen Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) 13.2.5 Amgen Recent Development 13.3 Pfizer 13.3.1 Pfizer Company Details 13.3.2 Pfizer Business Overview and Its Total Revenue 13.3.3 Pfizer Cancer Hormone Therapy Drugs Introduction 13.3.4 Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) 13.3.5 Pfizer Recent Development 13.4 Teva 13.4.1 Teva Company Details 13.4.2 Teva Business Overview and Its Total Revenue 13.4.3 Teva Cancer Hormone Therapy Drugs Introduction 13.4.4 Teva Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) 13.4.5 Teva Recent Development 13.5 Takeda 13.5.1 Takeda Company Details 13.5.2 Takeda Business Overview and Its Total Revenue 13.5.3 Takeda Cancer Hormone Therapy Drugs Introduction 13.5.4 Takeda Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) 13.5.5 Takeda Recent Development 13.6 Samyang Biopharmaceuticals 13.6.1 Samyang Biopharmaceuticals Company Details 13.6.2 Samyang Biopharmaceuticals Business Overview and Its Total Revenue 13.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Introduction 13.6.4 Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) 13.6.5 Samyang Biopharmaceuticals Recent Development 13.7 Tolmar 13.7.1 Tolmar Company Details 13.7.2 Tolmar Business Overview and Its Total Revenue 13.7.3 Tolmar Cancer Hormone Therapy Drugs Introduction 13.7.4 Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) 13.7.5 Tolmar Recent Development 13.8 AstraZeneca 13.8.1 AstraZeneca Company Details 13.8.2 AstraZeneca Business Overview and Its Total Revenue 13.8.3 AstraZeneca Cancer Hormone Therapy Drugs Introduction 13.8.4 AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) 13.8.5 AstraZeneca Recent Development 13.9 Novartis 13.9.1 Novartis Company Details 13.9.2 Novartis Business Overview and Its Total Revenue 13.9.3 Novartis Cancer Hormone Therapy Drugs Introduction 13.9.4 Novartis Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) 13.9.5 Novartis Recent Development 13.10 Aspen 13.10.1 Aspen Company Details 13.10.2 Aspen Business Overview and Its Total Revenue 13.10.3 Aspen Cancer Hormone Therapy Drugs Introduction 13.10.4 Aspen Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) 13.10.5 Aspen Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Cancer Hormone Therapy Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Cancer Hormone Therapy Drugs Revenue Table 3. Ranking of Global Top Cancer Hormone Therapy Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Tamoxifen Table 6. Key Players of Aromatase Inhibitors Table 7. Key Players of Antiandrogens Table 8. Key Players of Androgen Synthesis Inhibitors Table 9. Key Players of Other Table 10. Global Cancer Hormone Therapy Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Cancer Hormone Therapy Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Cancer Hormone Therapy Drugs Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Cancer Hormone Therapy Drugs Market Share by Regions (2015-2020) Table 14. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Cancer Hormone Therapy Drugs Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Cancer Hormone Therapy Drugs Market Growth Strategy Table 20. Main Points Interviewed from Key Cancer Hormone Therapy Drugs Players Table 21. Global Cancer Hormone Therapy Drugs Revenue by Players (2015-2020) (Million US$) Table 22. Global Cancer Hormone Therapy Drugs Market Share by Players (2015-2020) Table 23. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Hormone Therapy Drugs as of 2019) Table 24. Global Cancer Hormone Therapy Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Cancer Hormone Therapy Drugs Product Solution and Service Table 27. Date of Enter into Cancer Hormone Therapy Drugs Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$) Table 30. Global Cancer Hormone Therapy Drugs Market Size Share by Type (2015-2020) Table 31. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2021-2026) Table 32. Global Cancer Hormone Therapy Drugs Market Size Share by Application (2015-2020) Table 33. Global Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$) Table 34. Global Cancer Hormone Therapy Drugs Market Size Share by Application (2021-2026) Table 35. North America Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$) Table 36. North America Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020) Table 37. North America Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$) Table 38. North America Cancer Hormone Therapy Drugs Market Share by Type (2015-2020) Table 39. North America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$) Table 40. North America Cancer Hormone Therapy Drugs Market Share by Application (2015-2020) Table 41. Europe Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020) Table 43. Europe Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$) Table 44. Europe Cancer Hormone Therapy Drugs Market Share by Type (2015-2020) Table 45. Europe Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$) Table 46. Europe Cancer Hormone Therapy Drugs Market Share by Application (2015-2020) Table 47. China Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$) Table 48. China Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020) Table 49. China Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$) Table 50. China Cancer Hormone Therapy Drugs Market Share by Type (2015-2020) Table 51. China Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$) Table 52. China Cancer Hormone Therapy Drugs Market Share by Application (2015-2020) Table 53. Japan Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020) Table 55. Japan Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$) Table 56. Japan Cancer Hormone Therapy Drugs Market Share by Type (2015-2020) Table 57. Japan Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$) Table 58. Japan Cancer Hormone Therapy Drugs Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020) Table 61. Southeast Asia Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia Cancer Hormone Therapy Drugs Market Share by Type (2015-2020) Table 63. Southeast Asia Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia Cancer Hormone Therapy Drugs Market Share by Application (2015-2020) Table 65. India Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$) Table 66. India Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020) Table 67. India Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$) Table 68. India Cancer Hormone Therapy Drugs Market Share by Type (2015-2020) Table 69. India Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$) Table 70. India Cancer Hormone Therapy Drugs Market Share by Application (2015-2020) Table 71. Central & South America Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020) Table 73. Central & South America Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America Cancer Hormone Therapy Drugs Market Share by Type (2015-2020) Table 75. Central & South America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America Cancer Hormone Therapy Drugs Market Share by Application (2015-2020) Table 77. Roche Company Details Table 78. Roche Business Overview Table 79. Roche Product Table 80. Roche Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$) Table 81. Roche Recent Development Table 82. Amgen Company Details Table 83. Amgen Business Overview Table 84. Amgen Product Table 85. Amgen Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$) Table 86. Amgen Recent Development Table 87. Pfizer Company Details Table 88. Pfizer Business Overview Table 89. Pfizer Product Table 90. Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$) Table 91. Pfizer Recent Development Table 92. Teva Company Details Table 93. Teva Business Overview Table 94. Teva Product Table 95. Teva Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$) Table 96. Teva Recent Development Table 97. Takeda Company Details Table 98. Takeda Business Overview Table 99. Takeda Product Table 100. Takeda Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$) Table 101. Takeda Recent Development Table 102. Samyang Biopharmaceuticals Company Details Table 103. Samyang Biopharmaceuticals Business Overview Table 104. Samyang Biopharmaceuticals Product Table 105. Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$) Table 106. Samyang Biopharmaceuticals Recent Development Table 107. Tolmar Company Details Table 108. Tolmar Business Overview Table 109. Tolmar Product Table 110. Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$) Table 111. Tolmar Recent Development Table 112. AstraZeneca Business Overview Table 113. AstraZeneca Product Table 114. AstraZeneca Company Details Table 115. AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$) Table 116. AstraZeneca Recent Development Table 117. Novartis Company Details Table 118. Novartis Business Overview Table 119. Novartis Product Table 120. Novartis Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$) Table 121. Novartis Recent Development Table 122. Aspen Company Details Table 123. Aspen Business Overview Table 124. Aspen Product Table 125. Aspen Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$) Table 126. Aspen Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Hormone Therapy Drugs Market Share by Type: 2020 VS 2026 Figure 2. Tamoxifen Features Figure 3. Aromatase Inhibitors Features Figure 4. Antiandrogens Features Figure 5. Androgen Synthesis Inhibitors Features Figure 6. Other Features Figure 7. Global Cancer Hormone Therapy Drugs Market Share by Application: 2020 VS 2026 Figure 8. Breast Cancer Case Studies Figure 9. Prostate Cancer Case Studies Figure 10. Cancer Hormone Therapy Drugs Report Years Considered Figure 11. Global Cancer Hormone Therapy Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Cancer Hormone Therapy Drugs Market Share by Regions: 2020 VS 2026 Figure 13. Global Cancer Hormone Therapy Drugs Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Cancer Hormone Therapy Drugs Market Share by Players in 2019 Figure 16. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Hormone Therapy Drugs as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Cancer Hormone Therapy Drugs Revenue in 2019 Figure 18. North America Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Roche Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020) Figure 27. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Amgen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020) Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Pfizer Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020) Figure 31. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Teva Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020) Figure 33. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Takeda Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020) Figure 35. Samyang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Samyang Biopharmaceuticals Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020) Figure 37. Tolmar Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Tolmar Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020) Figure 39. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. AstraZeneca Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020) Figure 41. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Novartis Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020) Figure 43. Aspen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Aspen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020) Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Roche Amgen Pfizer Teva Takeda Samyang Biopharmaceuticals Tolmar AstraZeneca Novartis Aspen